Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin GOTHENBURG, Sweden, June 25, 2019 –…
Isofol Announces Election of Three New Board Members GOTHENBURG, Sweden, June 10, 2019 – Isofol Medical AB (publ) (Nasdaq First…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.